Cargando…

Incidence of metastasis and prostate-specific antigen levels at diagnosis in Gleason 3+4 versus 4+3 prostate cancer

AIMS: The aim is to assess for a difference in the incidence of metastasis (IM) and prostate-specific antigen (PSA) levels at diagnosis in patients with Gleason score (GS) 3+4 versus 4+3 prostate cancer using a large veterans affairs database. SUBJECTS AND METHODS: A retrospective review of 1402 med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamel, Mohamed H., Khalil, Mahmoud I., Alobuia, Wilson M., Su, Joseph, Davis, Rodney
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907332/ https://www.ncbi.nlm.nih.gov/pubmed/29719335 http://dx.doi.org/10.4103/UA.UA_124_17

Ejemplares similares

Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate Carcinoma
por: Chen, Yehui, et al.
Publicado: (2017)

Clinical significance of subtypes of Gleason pattern 4 prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2018)

The predictive factor for pathological downgrading after prostatectomy in patients with biopsy Gleason score 4+3 or 4+4 prostate cancer
por: Tohi, Yoichiro, et al.
Publicado: (2021)

Nomograms Predict Survival Advantages of Gleason Score 3+4 Over 4+3 for Prostate Cancer: A SEER-Based Study
por: Zhu, Xin, et al.
Publicado: (2019)

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer
por: Lehrer, S, et al.
Publicado: (2002)

The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
por: Ball, Richard Y., et al.
Publicado: (2021)

Molecular characterization of Gleason patterns 3 and 4 prostate cancer using reverse Warburg effect-associated genes
por: Georgescu, Ilinca, et al.
Publicado: (2016)

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
por: Pham, Duc Minh, et al.
Publicado: (2020)

The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6
por: Wang, Hanfeng, et al.
Publicado: (2017)

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer
por: Sharma, Meenal, et al.
Publicado: (2018)

The highest percentage of Gleason Pattern 4 is a predictor in intermediate‐risk prostate cancer
por: Sato, Shun, et al.
Publicado: (2022)

Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer
por: Nowroozi, Mohammad Reza, et al.
Publicado: (2016)

Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?
por: Montironi, Rodolfo, et al.
Publicado: (2014)

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)

Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
por: Mookerji, Nikhile, et al.
Publicado: (2023)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

ARRDC4 and UBXN1: Novel Target Genes Correlated with Prostate Cancer Gleason Score
por: Oh, Jong Jin, et al.
Publicado: (2021)

CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer
por: Qin, Xiao-Ping, et al.
Publicado: (2022)

pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
por: Kim, Sung Jin, et al.
Publicado: (2011)

Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
por: Bulten, Wouter, et al.
Publicado: (2022)

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
por: Seyrek, Neslisah, et al.
Publicado: (2021)

The gut microbiota associated with high‐Gleason prostate cancer
por: Matsushita, Makoto, et al.
Publicado: (2021)

Gleason 6 prostate cancer: That which cannot be named
por: Burke, Harry B.
Publicado: (2022)

Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria
por: Nnabugwu, Ikenna I, et al.
Publicado: (2016)

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
por: Thomsen, Frederik B., et al.
Publicado: (2020)

Biochemical Recurrence in Gleason Score 7 Prostate Cancer in Korean Men: Significance of the Primary Gleason Grade
por: Ro, Yun Kwan, et al.
Publicado: (2012)

Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer
por: Greenland, Nancy Y., et al.
Publicado: (2022)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
por: de Lima, Nelson Gianni, et al.
Publicado: (2013)

A novel prostate cancer immunotherapy using prostate-specific antigen peptides and Candida skin test reagent as an adjuvant
por: Abdallah, Al-Ola, et al.
Publicado: (2018)

Erratum: pT3 Predictive Factors in Patients with a Gleason Score of 6 in Prostate Biopsies
Publicado: (2011)

Correlation of apparent diffusion coefficient ratio on 3.0 T MRI with prostate cancer Gleason score
por: Jyoti, Rajeev, et al.
Publicado: (2018)

Validation of the WHO 2016 new Gleason score of prostatic carcinoma
por: Rao, Vishal, et al.
Publicado: (2018)

Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
por: Chaddad, Ahmad, et al.
Publicado: (2018)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores
por: Osorio, Clarice Fraga Esteves Maciel, et al.
Publicado: (2019)

Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes
por: Pascal, Laura E, et al.
Publicado: (2009)

A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on Biopsy
por: Albitar, Maher, et al.
Publicado: (2017)

Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
por: Galego, Pedro, et al.
Publicado: (2015)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
por: Makino, Tomoyuki, et al.
Publicado: (2016)

Inter-observer variability of cribriform architecture and percent Gleason pattern 4 in prostate cancer: relation to clinical outcome
por: van der Slot, Margaretha A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2o8udbn368b8lp657dmp27ifdg